Miry Blich1, Yeouda Edoute. 1. Rambam Medical Center, Internal Medicine C, Haifa, Israel. mblich@priza.co.il
Abstract
AIMS: To assess the effectiveness and to identify predictors for successful electrical cardioversion (ECV) and maintenance of sinus rhythm, in long term follow up of patients with persistent (PAF) and chronic atrial fibrillation (CAF). METHODS AND RESULTS: Retrospective analysis of medical records of 68 patients with PAF or CAF, who underwent 91 cardioversions. ECV was successful in 86 attempts (94.5%). In obese (body mass index>30) and hypertensive patients (blood pressure >140/90 mm Hg), ECV was less successful in restoring sinus rhythm (p<0.05, p<0.021, respectively). Sinus rhythm was maintained more than half a year in 42 cardioversions (61%). Treatment with beta blockers prior to cardioversion and age younger than 75 were independent factors predicting long term success (p<0.013, p<0.034, respectively). Mild or moderate enlargement of left atrium (<6 cm) did not predict relapse of the arrhythmia. Second ECV was as or more effective than the first in 82.3% of patients that underwent more than one cardioversion. CONCLUSIONS: Conversion of atrial fibrillation by DC shock was found to be safe and effective procedure. Patients should be treated with beta blockers prior to cardioversion, if possible. Mild or moderate enlargement of left atrium is not contraindication to cardioversion. Recurrent cardioversions may be recommended.
AIMS: To assess the effectiveness and to identify predictors for successful electrical cardioversion (ECV) and maintenance of sinus rhythm, in long term follow up of patients with persistent (PAF) and chronic atrial fibrillation (CAF). METHODS AND RESULTS: Retrospective analysis of medical records of 68 patients with PAF or CAF, who underwent 91 cardioversions. ECV was successful in 86 attempts (94.5%). In obese (body mass index>30) and hypertensivepatients (blood pressure >140/90 mm Hg), ECV was less successful in restoring sinus rhythm (p<0.05, p<0.021, respectively). Sinus rhythm was maintained more than half a year in 42 cardioversions (61%). Treatment with beta blockers prior to cardioversion and age younger than 75 were independent factors predicting long term success (p<0.013, p<0.034, respectively). Mild or moderate enlargement of left atrium (<6 cm) did not predict relapse of the arrhythmia. Second ECV was as or more effective than the first in 82.3% of patients that underwent more than one cardioversion. CONCLUSIONS: Conversion of atrial fibrillation by DC shock was found to be safe and effective procedure. Patients should be treated with beta blockers prior to cardioversion, if possible. Mild or moderate enlargement of left atrium is not contraindication to cardioversion. Recurrent cardioversions may be recommended.
Authors: Brian O Bingen; Saïd F A Askar; Zeinab Neshati; Iolanda Feola; Alexander V Panfilov; Antoine A F de Vries; Daniël A Pijnappels Journal: Sci Rep Date: 2015-10-21 Impact factor: 4.379
Authors: Gregory Y H Lip; Jose L Merino; Maciej Banach; Naab Al-Saady; James Jin; Michael Melino; Shannon M Winters; Monika Kozieł; Andreas Goette Journal: J Arrhythm Date: 2020-04-15
Authors: Eva A H Lanters; Denise M S van Marion; Charles Kik; Herman Steen; Ad J J C Bogers; Maurits A Allessie; Bianca J J M Brundel; Natasja M S de Groot Journal: J Transl Med Date: 2015-11-05 Impact factor: 5.531